Advocacy Webpage Graphics Teach It
TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma
Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of individualized addiction treatment so that more patients receive high-quality, evidence-based care
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to comprehensive, high-quality addiction care

Leading the movement to transform America's addiction treatment infrastructure and expand access to research-validated, results-based care


ASAM Policy Principles

ASAM believes in a future in which addiction prevention, treatment, remission, and recovery are accessible to all, and where they profoundly improve the health of all people. The following principles guide our advocacy and shape ASAM's advocacy priorities:
  • Addiction policy should be guided by - and promote the use of - the latest science and best practices in addiction prevention, treatment, remission, and recovery.  People with addiction deserve compassionate, evidence-based care that addresses the chronic nature of the disease of addiction.
  • Strategic and multifaceted policy solutions are needed to drive the development of a more accessible, effective, robust, and comprehensive addiction prevention and treatment infrastructure.
  • Policies and payment systems should ensure equitable access to comprehensive, high-quality addiction prevention, treatment, and recovery services.
  • Policy should challenge, rather than enforce, cultural misunderstanding, stigma and discrimination about the disease of addiction.
  • Addiction policy and advocacy should respect and integrate the perspectives of people with addiction and their families.

NJSAM Submits Letter in Support of Bill to Improve Access to MAT in Jails and Prisons

by | Mar 25, 2020


On March 25, the New Jersey Society of Addiction Medicine (NJSAM), submitted a letter in support of A3692, which would require New Jersey’s department of corrections to ensure that incarcerated individuals in need of temporary or continued management of a substance use disorder in the state have access to medications for addiction treatment (MAT) as well as counseling services and withdrawal management services.


The letter noted the efficacy of MAT when used to treat opioid use disorder (OUD), focusing specifically on its ability to decrease recidivism and patient mortality. Furthermore, MAT continues to accrue evidence in support of its effectiveness at reducing infectious disease transmission both inside jails and prisons, but also in the community.


Read the bill here.


Read NJSAM’s letter here.